Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × envafolimab × Clear all

NCT06059261 2026-02-18

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Phase 2 Recruiting

Nasopharyngeal Carcinoma